By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Shire Pharmaceuticals Group plc 

Hampshire International Business Park
Basingstoke  Hampshire  RG24 8EP  United Kingdom
Phone: 44-1256-894-000 Fax: 44-1256-894-708



Company News
Shire (SHPGY) Receives CHMP Positive Opinion In Europe For INTUNIV (guanfacine hydrochloride extended release) As A Non-Stimulant ADHD Treatment For Children And Adolescents 7/23/2015 2:00:28 PM
Shire (SHPGY) Announces Second Quarter Earnings And Increases Full Year Non GAAP Diluted EPS Guidance To Mid-To-High Single Digit Growth 7/23/2015 12:18:11 PM
Shire (SHPGY): Life One Year After a $54 Billion Takeover Collapse by AbbVie (ABBV) and Its Push Into Biotech 7/14/2015 6:43:02 AM
Shire (SHPGY) Launches Spotlight On Gaucher Film Contest And Calls For Video Entries Sharing Experiences Of Living With Gaucher Disease 7/1/2015 3:00:05 PM
Shire (SHPGY) Names Bill Mordan General Counsel And Corporate Secretary; Appoints Michele Galen Head Of Communications And Public Affairs 6/15/2015 7:26:16 AM
ArmaGen Technologies, Inc. Achieves Clinical Milestone In Hunter Syndrome Collaboration With Shire (SHPGY) 6/15/2015 6:20:05 AM
Shire (SHPGY) Appoints Olivier Bohuon To Its Board Of Directors 6/11/2015 7:05:02 AM
Alexion (ALXN), BioMarin (BMRN), Sanofi (SAN.PA), Shire (SHPGY) May Be Eyeing Dyax Corp. (DYAX) and Its Rare Genetic Disorder Drug 6/11/2015 6:27:19 AM
Actelion (ALIOF.PK) Hits All Time High on Rumored $18.9 Billion Shire (SHPGY) Bid 6/8/2015 5:56:01 AM
Shire (SHPGY) To Participate At The Jefferies and Co. 2015 Global Healthcare Conference 6/1/2015 12:30:18 PM